Philippe Vervliet

538 total citations
20 papers, 432 citations indexed

About

Philippe Vervliet is a scholar working on Health, Toxicology and Mutagenesis, Molecular Biology and Orthodontics. According to data from OpenAlex, Philippe Vervliet has authored 20 papers receiving a total of 432 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Health, Toxicology and Mutagenesis, 6 papers in Molecular Biology and 5 papers in Orthodontics. Recurrent topics in Philippe Vervliet's work include Effects and risks of endocrine disrupting chemicals (11 papers), Dental materials and restorations (5 papers) and Metabolomics and Mass Spectrometry Studies (4 papers). Philippe Vervliet is often cited by papers focused on Effects and risks of endocrine disrupting chemicals (11 papers), Dental materials and restorations (5 papers) and Metabolomics and Mass Spectrometry Studies (4 papers). Philippe Vervliet collaborates with scholars based in Belgium, Luxembourg and United States. Philippe Vervliet's co-authors include Adrian Covaci, Radu Corneliu Duca, Siemon De Nys, Imke Boonen, Marc Elskens, Kirsten Van Landuyt, Lode Godderis, Celine Gys, Jeroen Vanoirbeek and Bart Van Meerbeek and has published in prestigious journals such as Analytical Chemistry, Scientific Reports and Journal of Chromatography A.

In The Last Decade

Philippe Vervliet

20 papers receiving 428 citations

Peers

Countries citing papers authored by Philippe Vervliet

Since Specialization

Citations

This map shows the geographic impact of Philippe Vervliet's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Philippe Vervliet with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Philippe Vervliet more than expected).

Fields of papers citing papers by Philippe Vervliet

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Philippe Vervliet. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Philippe Vervliet. The network helps show where Philippe Vervliet may publish in the future.

Co-authorship network of co-authors of Philippe Vervliet

This figure shows the co-authorship network connecting the top 25 collaborators of Philippe Vervliet. A scholar is included among the top collaborators of Philippe Vervliet based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Philippe Vervliet. Philippe Vervliet is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Degradation products of resin-based materials detected in saliva in vivo 2023 ·Clinical Oral Investigations ·Philippe Vervliet, Siemon De Nys, Radu Corneliu Duca, Imke Boonen, Lode Godderis, Marc Elskens, Kirsten Van Landuyt, Adrian Covaci	5
2	Logistic Regression Analysis of LC-MS/MS Data of Monomers Eluted from Aged Dental Composites: A Supervised Machine-Learning Approach 2023 ·Analytical Chemistry ·(unknown), (unknown), Philippe Vervliet, Adrian Covaci, (unknown), Karl J. Rockne, James L. Drummond, Luke Hanley	9
3	Identification of Potential Urinary Metabolite Biomarkers of Pseudomonas aeruginosa Ventilator-Associated Pneumonia 2022 ·Biomarker Insights ·(unknown), An Hotterbeekx, (unknown), Philippe Vervliet, (unknown), Christine Lammens, Erik Fransen, Geert Baggerman, Adrian Covaci, Herman Goossens, Surbhi Malhotra‐Kumar, Philippe G. Jorens, Samir Kumar‐Singh	5
4	Towards harmonised criteria in quality assurance and quality control of suspect and non-target LC-HRMS analytical workflows for screening of emerging contaminants in human biomonitoring 2021 ·TrAC Trends in Analytical Chemistry ·Noelia Caballero‐Casero, Lidia Belova, Philippe Vervliet, Jean‐Philippe Antignac, Argelia Castaño, Laurent Debrauwer, Marta Esteban, Carolin Huber, Jana Klánová, Martin Krauß, Arjen Lommen, Hans Mol, Herbert Oberacher, Olga Pardo, Elliott J. Price, Vera Reinstadler, Chiara Maria Vitale, Alexander L.N. van Nuijs, Adrian Covaci	47
5	Bisphenol A release from short-term degraded resin-based dental materials 2021 ·Journal of Dentistry ·Siemon De Nys, Radu Corneliu Duca, Philippe Vervliet, Adrian Covaci, Imke Boonen, Marc Elskens, Jeroen Vanoirbeek, Lode Godderis, Bart Van Meerbeek, Kirsten Van Landuyt	21
6	Bisphenol A as degradation product of monomers used in resin-based dental materials 2021 ·Dental Materials ·Siemon De Nys, Radu Corneliu Duca, Philippe Vervliet, Adrian Covaci, Imke Boonen, Marc Elskens, Jeroen Vanoirbeek, Lode Godderis, Bart Van Meerbeek, Kirsten Van Landuyt	38
7	Identification of chemicals leaching from dental resin-based materials after in vitro chemical and salivary degradation 2021 ·Dental Materials ·Philippe Vervliet, Siemon De Nys, Radu Corneliu Duca, Imke Boonen, Lode Godderis, Marc Elskens, Kirsten Van Landuyt, Adrian Covaci	16
8	Long-term elution of bisphenol A from dental composites 2021 ·Dental Materials ·Siemon De Nys, Eveline Putzeys, Radu Corneliu Duca, Philippe Vervliet, Adrian Covaci, Imke Boonen, Marc Elskens, Jeroen Vanoirbeek, Lode Godderis, Bart Van Meerbeek, Kirsten Van Landuyt	19
9	Assessing the estrogenic activity of chemicals present in resin based dental composites and in leachates of commercially available composites using the ERα-CALUX bioassay 2021 ·Dental Materials ·Imke Boonen, Siemon De Nys, Philippe Vervliet, Adrian Covaci, Kirsten Van Landuyt, Radu Corneliu Duca, Lode Godderis, Michael S. Denison, Marc Elskens	11
10	Human phase I in vitro liver metabolism of two bisphenolic diglycidyl ethers BADGE and BFDGE 2020 ·Toxicology Letters ·Philippe Vervliet, Siemon De Nys, Radu Corneliu Duca, Imke Boonen, Lode Godderis, Marc Elskens, Kirsten Van Landuyt, Adrian Covaci	12
11	A comparative study on the in vitro biotransformation of medicagenic acid using human liver microsomes and S9 fractions 2020 ·Chemico-Biological Interactions ·(unknown), Philippe Vervliet, Kenn Foubert, Nina Hermans, Luc Pieters, Adrian Covaci	10
12	Current-use of developers in thermal paper from 14 countries using liquid chromatography coupled to quadrupole time-of-flight mass spectrometry 2019 ·Toxicology ·Philippe Vervliet, Celine Gys, Noelia Caballero‐Casero, Adrian Covaci	35
13	Investigating the in vitro metabolism of the dental resin monomers BisGMA, BisPMA, TCD-DI-HEA and UDMA using human liver microsomes and quadrupole time of flight mass spectrometry 2019 ·Toxicology ·Philippe Vervliet, (unknown), Siemon De Nys, Radu Corneliu Duca, Imke Boonen, Marc Elskens, Kirsten Van Landuyt, Adrian Covaci	21
14	Suspect and non-target screening workflows to investigate the in vitro and in vivo metabolism of the synthetic cannabinoid 5-Cl-THJ-018 2019 ·Annales de Toxicologie Analytique ·(unknown), Philippe Vervliet, (unknown), (unknown), Kristof E. Maudens, Adrian Covaci, Alexander L.N. van Nuijs, (unknown)	3
15	Qualitative analysis of dental material ingredients, composite resins and sealants using liquid chromatography coupled to quadrupole time of flight mass spectrometry 2018 ·Journal of Chromatography A ·Philippe Vervliet, Siemon De Nys, Imke Boonen, Radu Corneliu Duca, Marc Elskens, Kirsten Van Landuyt, Adrian Covaci	35
16	A novel high sensitivity UPLC-MS/MS method for the evaluation of bisphenol A leaching from dental materials 2018 ·Scientific Reports ·Siemon De Nys, Eveline Putzeys, Philippe Vervliet, Adrian Covaci, Imke Boonen, Marc Elskens, Jeroen Vanoirbeek, Lode Godderis, Bart Van Meerbeek, Kirsten Van Landuyt, Radu Corneliu Duca	34
17	Suspect and non‐target screening workflows to investigate the in vitro and in vivo metabolism of the synthetic cannabinoid 5Cl‐THJ‐018 2018 ·Drug Testing and Analysis ·Philippe Vervliet, (unknown), Celine Gys, (unknown), Katrien Lanckmans, Kristof E. Maudens, Adrian Covaci, Alexander L.N. van Nuijs, Foon Yin Lai	22
18	In vitro Phase I and Phase II metabolism of the new designer benzodiazepine cloniprazepam using liquid chromatography coupled to quadrupole time-of-flight mass spectrometry 2018 ·Journal of Pharmaceutical and Biomedical Analysis ·(unknown), Philippe Vervliet, Celine Gys, (unknown), Matthias Cuykx, Kristof E. Maudens, Adrian Covaci, Alexander L.N. van Nuijs, Foon Yin Lai	29
19	invitRo - In vitro HLM assay feature prioritization 2018 ·Zenodo (CERN European Organization for Nuclear Research) ·Philippe Vervliet	4
20	Development and application of a non-targeted extraction method for the analysis of migrating compounds from plastic baby bottles by GC-MS 2014 ·Food Additives & Contaminants Part A ·Matthias Onghena, Els Van Hoeck, Philippe Vervliet, (unknown), (unknown), Joris Van Loco, Adrian Covaci	56

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact